Filing Details
- Accession Number:
- 0001144204-10-015659
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-25 13:00:00
- Reporting Period:
- 2010-03-23
- Filing Date:
- 2010-03-25
- Accepted Time:
- 2010-03-25 16:46:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1251213 | Ron Bentsur | 750 Lexington Ave 20Th Fl New York NY 10021 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-03-23 | 250,000 | $0.00 | 642,221 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2010-03-24 | 31,089 | $2.95 | 611,132 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Mr. Bentsur received 250,000 shares of restricted common stock of Keryx Biopharmaceuticals, Inc. pursuant to the terms of his employment agreement. The restricted common stock vests as follows: 83,333 vest on March 23, 2011; 83,333 vest on March 23, 2012; and the remainder vest on March 23, 2013.
- Sale of shares of common stock was made in order to satisfy Mr. Bentsur's income tax withholding obligation upon the vesting of shares of restricted stock.
Billionaire Hedge Funds
